Tempus AI (NASDAQ:TEM) Share Price Crosses Above 50-Day Moving Average – Time to Sell?

Tempus AI, Inc. (NASDAQ:TEM) shares passed above its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $71.32 and traded as high as $76.85. Tempus AI shares last traded at $76.05, with a volume of 6,279,076 shares.

Analysts Set New Price Targets

TEM has been the topic of several research reports. Stifel Nicolaus decreased their target price on Tempus AI from $60.00 to $50.00 and set a “hold” rating on the stock in a research report on Monday, August 3rd. JPMorgan Chase & Co. upped their target price on shares of Tempus AI from $45.00 to $70.00 and gave the company a “neutral” rating in a report on Wednesday, October 14th. UBS Group assumed coverage on shares of Tempus AI in a research report on Wednesday, September 9th. They set a “neutral” rating and a $70.00 target price for the company. Robert W. Baird raised their price target on Tempus AI from $85.00 to $92.00 and gave the company an “outperform” rating in a report on Tuesday. Finally, BTIG Research lifted their target price on shares of Tempus AI from $80.00 to $100.00 and gave the company a “buy” rating in a report on Tuesday. Eleven investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $79.37.

Tempus AI Stock Performance

The company has a fifty day moving average price of $71.32 and a two-hundred day moving average price of $57.25. The company has a debt-to-equity ratio of 3.06, a current ratio of 3.30 and a quick ratio of 3.16. The company has a market capitalization of $13.72 billion, a P/E ratio of -71.75 and a beta of 3.61.

Tempus AI (NASDAQ:TEM) last posted its quarterly earnings data on Monday, November 2nd. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of ($0.09) by $0.16. The firm had revenue of $411.54 million for the quarter, compared to analysts’ expectations of $409.39 million. Tempus AI had a negative net margin of 12.54% and a negative return on equity of 48.29%. The business’s quarterly revenue was up 23.1% on a year-over-year basis. During the same quarter last year, the company posted ($0.46) EPS. Equities analysts forecast that Tempus AI, Inc. will post -1.45 earnings per share for the current fiscal year.

Insider Activity

In other news, CEO Ryan Fukushima sold 41,095 shares of Tempus AI stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $49.61, for a total value of $2,038,722.95. Following the sale, the chief executive officer owned 562,463 shares of the company’s stock, valued at $27,903,789.43. The trade was a 6.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, EVP Andrew Polovin sold 22,148 shares of Tempus AI stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $49.61, for a total transaction of $1,098,762.28. Following the completion of the sale, the executive vice president owned 146,067 shares of the company’s stock, valued at approximately $7,246,383.87. This trade represents a 13.17% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders have sold 1,237,227 shares of company stock worth $85,388,983. 24.26% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Tempus AI

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. V Square Quantitative Management LLC bought a new position in shares of Tempus AI during the 3rd quarter valued at $27,000. EMC Capital Management acquired a new position in shares of Tempus AI in the second quarter worth $29,000. Whittier Trust Co. raised its holdings in shares of Tempus AI by 190.0% in the first quarter. Whittier Trust Co. now owns 870 shares of the company’s stock valued at $41,000 after buying an additional 570 shares during the last quarter. Ulland Investment Advisors LLC purchased a new stake in Tempus AI in the 3rd quarter valued at approximately $41,000. Finally, Heritage Family Offices LLP acquired a new position in shares of Tempus AI during the 3rd quarter valued at $45,000. Institutional investors own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI, Inc is a healthcare technology company that uses artificial intelligence and data analytics to support precision medicine. The company combines clinical, molecular and imaging data to help physicians make more informed treatment decisions and to help researchers and biopharmaceutical companies develop therapies.

Its offerings include genomic testing and analysis, such as tissue- and blood-based tests, as well as software tools designed to assist with clinical decision-making, patient matching for clinical trials and the management of healthcare data.